Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

422 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Bi-weekly chemotherapy with cisplatin, epirubicin, folinic acid and 5-fluororacil continuous infusion plus g-csf in advanced gastric cancer: a multicentric phase II study.
Felici A, Carlini P, Ruggeri EM, Gamucci T, Pollera CF, De Marco S, Fariello AM, Moscetti L, Gelibter A, Adami E, Sperduti I, Cognetti F. Felici A, et al. Among authors: sperduti i. Cancer Chemother Pharmacol. 2006 Jan;57(1):59-64. doi: 10.1007/s00280-005-0032-5. Epub 2005 Nov 5. Cancer Chemother Pharmacol. 2006. PMID: 16001173 Clinical Trial.
A phase II study on metastatic breast cancer patients treated with weekly vinorelbine with or without trastuzumab according to HER2 expression: changing the natural history of HER2-positive disease.
Papaldo P, Fabi A, Ferretti G, Mottolese M, Cianciulli AM, Di Cocco B, Pino MS, Carlini P, Di Cosimo S, Sacchi I, Sperduti I, Nardoni C, Cognetti F. Papaldo P, et al. Among authors: sperduti i. Ann Oncol. 2006 Apr;17(4):630-6. doi: 10.1093/annonc/mdj110. Epub 2006 Jan 12. Ann Oncol. 2006. PMID: 16410363 Free article. Clinical Trial.
Weekly paclitaxel, 5-fluorouracil and folinic acid with granulocyte colony-stimulating factor support in metastatic breast cancer patients: a phase II study.
Nistico C, Bria E, Agostara B, Barni S, Colella E, Frontini L, D'Ottavio AM, Cuppone F, Valenza R, Sperduti I, Izzo F, Terzoli E. Nistico C, et al. Among authors: sperduti i. Anticancer Drugs. 2006 Mar;17(3):345-51. doi: 10.1097/00001813-200603000-00014. Anticancer Drugs. 2006. PMID: 16520664 Clinical Trial.
Up-front chemotherapy and radiation treatment in newly diagnosed nonsmall cell lung cancer with brain metastases: survey by Outcome Research Network for Evaluation of Treatment Results in Oncology.
Moscetti L, Nelli F, Felici A, Rinaldi M, De Santis S, D'Auria G, Mansueto G, Tonini G, Sperduti I, Pollera FC. Moscetti L, et al. Among authors: sperduti i. Cancer. 2007 Jan 15;109(2):274-81. doi: 10.1002/cncr.22399. Cancer. 2007. PMID: 17154161 Free article.
Cardiotoxicity and incidence of brain metastases after adjuvant trastuzumab for early breast cancer: the dark side of the moon? A meta-analysis of the randomized trials.
Bria E, Cuppone F, Fornier M, Nisticò C, Carlini P, Milella M, Sperduti I, Terzoli E, Cognetti F, Giannarelli D. Bria E, et al. Among authors: sperduti i. Breast Cancer Res Treat. 2008 May;109(2):231-9. doi: 10.1007/s10549-007-9663-z. Epub 2007 Jul 19. Breast Cancer Res Treat. 2008. PMID: 17638068 Review.
422 results